EP0661592A1 - Symmetrical radiographic assembly for chest examination - Google Patents
Symmetrical radiographic assembly for chest examination Download PDFInfo
- Publication number
- EP0661592A1 EP0661592A1 EP93121047A EP93121047A EP0661592A1 EP 0661592 A1 EP0661592 A1 EP 0661592A1 EP 93121047 A EP93121047 A EP 93121047A EP 93121047 A EP93121047 A EP 93121047A EP 0661592 A1 EP0661592 A1 EP 0661592A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- silver halide
- radiographic
- halide emulsion
- radiographic element
- coated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 silver halide Chemical class 0.000 claims abstract description 154
- 239000000839 emulsion Substances 0.000 claims abstract description 140
- 229910052709 silver Inorganic materials 0.000 claims abstract description 117
- 239000004332 silver Substances 0.000 claims abstract description 117
- 238000000034 method Methods 0.000 claims abstract description 24
- 238000001228 spectrum Methods 0.000 claims abstract description 21
- 230000008569 process Effects 0.000 claims abstract description 14
- 230000005855 radiation Effects 0.000 claims description 22
- 230000035945 sensitivity Effects 0.000 claims description 18
- 239000000084 colloidal system Substances 0.000 claims description 4
- 239000010410 layer Substances 0.000 description 102
- 108010010803 Gelatin Proteins 0.000 description 27
- 229920000159 gelatin Polymers 0.000 description 27
- 235000019322 gelatine Nutrition 0.000 description 27
- 235000011852 gelatine desserts Nutrition 0.000 description 27
- 239000008273 gelatin Substances 0.000 description 25
- 239000000975 dye Substances 0.000 description 24
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- 239000004848 polyfunctional curative Substances 0.000 description 17
- 229910052761 rare earth metal Inorganic materials 0.000 description 16
- 238000000576 coating method Methods 0.000 description 14
- 239000011248 coating agent Substances 0.000 description 13
- 230000003595 spectral effect Effects 0.000 description 13
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 12
- 239000000758 substrate Substances 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 10
- 239000000123 paper Substances 0.000 description 10
- 239000011241 protective layer Substances 0.000 description 10
- 239000011230 binding agent Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 238000002601 radiography Methods 0.000 description 8
- 230000001235 sensitizing effect Effects 0.000 description 8
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 229920000728 polyester Polymers 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 150000002910 rare earth metals Chemical class 0.000 description 6
- 229910052771 Terbium Inorganic materials 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 229910052736 halogen Inorganic materials 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 5
- 229910052688 Gadolinium Inorganic materials 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 229910052746 lanthanum Inorganic materials 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000002491 polymer binding agent Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- 229910052765 Lutetium Inorganic materials 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 229910021612 Silver iodide Inorganic materials 0.000 description 3
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 3
- AMTXUWGBSGZXCJ-UHFFFAOYSA-N benzo[e][1,3]benzoselenazole Chemical compound C1=CC=C2C(N=C[se]3)=C3C=CC2=C1 AMTXUWGBSGZXCJ-UHFFFAOYSA-N 0.000 description 3
- WMUIZUWOEIQJEH-UHFFFAOYSA-N benzo[e][1,3]benzoxazole Chemical compound C1=CC=C2C(N=CO3)=C3C=CC2=C1 WMUIZUWOEIQJEH-UHFFFAOYSA-N 0.000 description 3
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 229920001600 hydrophobic polymer Polymers 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 229920006267 polyester film Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 229940045105 silver iodide Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 3
- AIGNCQCMONAWOL-UHFFFAOYSA-N 1,3-benzoselenazole Chemical compound C1=CC=C2[se]C=NC2=C1 AIGNCQCMONAWOL-UHFFFAOYSA-N 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N 3H-indole Chemical compound C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- MVVFUAACPKXXKJ-UHFFFAOYSA-N 4,5-dihydro-1,3-selenazole Chemical compound C1CN=C[Se]1 MVVFUAACPKXXKJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- KXNQKOAQSGJCQU-UHFFFAOYSA-N benzo[e][1,3]benzothiazole Chemical compound C1=CC=C2C(N=CS3)=C3C=CC2=C1 KXNQKOAQSGJCQU-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 2
- 229950005308 oxymethurea Drugs 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 125000005504 styryl group Chemical group 0.000 description 2
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 2
- DLQKNXAWCPRERG-UHFFFAOYSA-N terbium thulium Chemical compound [Tb][Tm] DLQKNXAWCPRERG-UHFFFAOYSA-N 0.000 description 2
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- SOBDFTUDYRPGJY-UHFFFAOYSA-N 1,3-bis(ethenylsulfonyl)propan-2-ol Chemical compound C=CS(=O)(=O)CC(O)CS(=O)(=O)C=C SOBDFTUDYRPGJY-UHFFFAOYSA-N 0.000 description 1
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical compound C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 1
- IJHIIHORMWQZRQ-UHFFFAOYSA-N 1-(ethenylsulfonylmethylsulfonyl)ethene Chemical compound C=CS(=O)(=O)CS(=O)(=O)C=C IJHIIHORMWQZRQ-UHFFFAOYSA-N 0.000 description 1
- SIQZJFKTROUNPI-UHFFFAOYSA-N 1-(hydroxymethyl)-5,5-dimethylhydantoin Chemical compound CC1(C)N(CO)C(=O)NC1=O SIQZJFKTROUNPI-UHFFFAOYSA-N 0.000 description 1
- BWDCHHPDRMATGI-UHFFFAOYSA-N 1-[1,2-bis(ethenylsulfonyl)ethoxy]-1,2-bis(ethenylsulfonyl)ethane Chemical compound C=CS(=O)(=O)CC(S(=O)(=O)C=C)OC(S(=O)(=O)C=C)CS(=O)(=O)C=C BWDCHHPDRMATGI-UHFFFAOYSA-N 0.000 description 1
- SAVMNSHHXUMFRQ-UHFFFAOYSA-N 1-[bis(ethenylsulfonyl)methoxy-ethenylsulfonylmethyl]sulfonylethene Chemical compound C=CS(=O)(=O)C(S(=O)(=O)C=C)OC(S(=O)(=O)C=C)S(=O)(=O)C=C SAVMNSHHXUMFRQ-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- USYCQABRSUEURP-UHFFFAOYSA-N 1h-benzo[f]benzimidazole Chemical compound C1=CC=C2C=C(NC=N3)C3=CC2=C1 USYCQABRSUEURP-UHFFFAOYSA-N 0.000 description 1
- HIYWOHBEPVGIQN-UHFFFAOYSA-N 1h-benzo[g]indole Chemical class C1=CC=CC2=C(NC=C3)C3=CC=C21 HIYWOHBEPVGIQN-UHFFFAOYSA-N 0.000 description 1
- YKUDHBLDJYZZQS-UHFFFAOYSA-N 2,6-dichloro-1h-1,3,5-triazin-4-one Chemical compound OC1=NC(Cl)=NC(Cl)=N1 YKUDHBLDJYZZQS-UHFFFAOYSA-N 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- GTZVMEHLIMDKTK-UHFFFAOYSA-N 3,3-dimethylindole Chemical compound C1=CC=C2C(C)(C)C=NC2=C1 GTZVMEHLIMDKTK-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 208000029152 Small face Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 229920002433 Vinyl chloride-vinyl acetate copolymer Polymers 0.000 description 1
- 229920001986 Vinylidene chloride-vinyl chloride copolymer Polymers 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- HOLVRJRSWZOAJU-UHFFFAOYSA-N [Ag].ICl Chemical compound [Ag].ICl HOLVRJRSWZOAJU-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000002742 anti-folding effect Effects 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- OYLGJCQECKOTOL-UHFFFAOYSA-L barium fluoride Chemical compound [F-].[F-].[Ba+2] OYLGJCQECKOTOL-UHFFFAOYSA-L 0.000 description 1
- 229910001632 barium fluoride Inorganic materials 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical class [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- BVVBQOJNXLFIIG-UHFFFAOYSA-N benzo[g][1,3]benzoxazole Chemical compound C1=CC=CC2=C(OC=N3)C3=CC=C21 BVVBQOJNXLFIIG-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000004799 bromophenyl group Chemical group 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000006627 ethoxycarbonylamino group Chemical group 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 150000002344 gold compounds Chemical class 0.000 description 1
- PDMYFWLNGXIKEP-UHFFFAOYSA-K gold(3+);trithiocyanate Chemical compound [Au+3].[S-]C#N.[S-]C#N.[S-]C#N PDMYFWLNGXIKEP-UHFFFAOYSA-K 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- JEUXZUSUYIHGNL-UHFFFAOYSA-N n,n-diethylethanamine;hydrate Chemical compound O.CCN(CC)CC JEUXZUSUYIHGNL-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- HRILWXJIWQHJMT-UHFFFAOYSA-M sodium;(4-methylphenyl)-oxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=S)C=C1 HRILWXJIWQHJMT-UHFFFAOYSA-M 0.000 description 1
- KFZUDNZQQCWGKF-UHFFFAOYSA-M sodium;4-methylbenzenesulfinate Chemical compound [Na+].CC1=CC=C(S([O-])=O)C=C1 KFZUDNZQQCWGKF-UHFFFAOYSA-M 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/46—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein having more than one photosensitive layer
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/16—X-ray, infrared, or ultraviolet ray processes
- G03C5/17—X-ray, infrared, or ultraviolet ray processes using screens to intensify X-ray images
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C2200/00—Details
- G03C2200/58—Sensitometric characteristics
Definitions
- the present invention relates to a combination of photosensitive elements for use in radiography. More specifically, the present invention relates to a double-side coated silver halide radiographic element for use in medical radiography, preferably for chest diagnostic imaging, and to the combination thereof with a pair of fluorescent phosphor screens.
- Intensifying screens absorb the X-ray radiation and emit electromagnetic radiations which can be better absorbed by silver halide emulsion layers.
- Another approach to reduce the X-ray dosage to the patient is to coat two silver halide emulsion layers on the opposite sides of a support to form a duplitized radiographic element.
- One of the problems of medical radiography relates to the different X-ray absorption of the various parts of the body.
- chest radiography the heart area has an absorption ten times higher than the lung area.
- a similar effect occurs in the radiography of the stomach, where a contrast medium is used in order to enhance the image depictivity (the part of the body having no contrast medium being totally black), and of hands and legs, where bones have an X-ray absorption higher than that of soft tissues such as flesh and cartilage.
- a radiographic element showing a low contrast is required for an area of high X-ray absorption and a radiographic element showing a high contrast is required for an area of low X-ray absorption.
- the resulting film is a compromise in an attempt to have sufficient optical density and sharpness for these different areas of the body.
- X-ray images providing visually discernible features in both the heart and lung image areas are attempted by using extended latitude radiographic elements.
- Extended latitude radiographic elements typically employ polydispersed silver halide emulsions to provide lower average contrasts and a wider range of exposures separating minimum and maximum density exposures.
- Said extended latitude radiographic elements do not provide the desired sensitometric curve necessary to obtain visually useful imaging details in both heart and lung areas.
- the optimal sensitometric curve for obtaining good imaging information in both regions of low and high X-ray absorption is shown in Fig. 1.
- Various methods have been suggested to solve the problem of needing different contrast capabilities for different areas of the body.
- One approach relates to the use of double coated radiographic elements having a different emulsion layer coated on each side of the support.
- DE 1,017,464 discloses a double coated radiographic element having coated thereon a first emulsion with high sensitivity and low contrast and a second emulsion with low sensitivity and high contrast
- FR 885,707 discloses a double coated radiographic element having coated thereon a first high speed emulsion and a second high contrast emulsion
- FR 875,269 discloses a radiographic assembly comprising several radiographic films or papers, each having a different sensitivity and/or contrast relative to the others, in order to obtain separate and different images of the same object with a single exposure.
- FR 787,017 discloses a radiographic element comprising silver halide emulsion layers of different color sensitivity to be combined with intensifying screens emitting radiation to which the silver halides are sensitive. The purpose of this patent is to obtain an increased use of radiation.
- EP 88,820 discloses a radiographic fluorescent screen comprising a first blue emitting phosphor layer and a second green emitting phosphor layer to be combined with a silver halide element having spectral sensitivity in the blue-green region ("ortho-type" elements).
- JP 60-175000 discloses a combination of a double coated silver halide element and a screen pair wherein the fluorescent layers of the two screens have different wavelength region emissions and each screen comprises an organic dye to absorb the light emitted by the opposite screen.
- EP 350,883 discloses a technique for crossover reduction in which silver halide emulsion layers having different color sensitivities are provided on the opposite sides of a transparent support, and X-ray fluorescent intensifying screens having emission spectra corresponding to the respective color sensitivities are used.
- EP 126,644 describes a radiographic material having a characteristic curve whose gamma between optical densities of 0.50 and 1.50 is 2.7 to 3.3 and gamma between optical densities of 2.00 and 3.00 is 1.5 to 2.5, said material having a wide exposure latitude to make possible the production of images having high diagnostic ability.
- This invention relates to a double side radiographic element which comprises a support and at least two silver halide emulsion layers coated on each side of said support, wherein said at least two silver halide emulsion layers show a speed difference of at least 0.3 logE and are both sensitive to the same region of the electromagnetic spectrum, and wherein said double side radiographic element shows a sensitometric curve having a toe contrast value higher than 0.45 and an average contrast higher than 1.40.
- this invention relates to a symmetrical radiographic assembly comprising:
- each side of said support are coated at least two silver halide emulsion layers having a speed difference of at least 0.3 logE, said at least two silver halide emulsion layers being each sensitive to the same region of the electromagnetic spectrum,
- said intensifying screen comprises a light emitting phosphor selected to have a radiation light emission having an emission maximum wavelength corresponding to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive, and
- said double side radiographic element shows a sensitometric curve having a toe contrast value higher than 0.45 and an average contrast higher than 1.40.
- the present invention relates to a process for obtaining a radiographic image comprising the step of (a) image-wise exposing to an X-ray radiation which has passed through an object, a symmetrical radiographic assembly comprising (i) a double side radiographic element having a support and at least two silver halide emulsion layers having a speed difference of at least 0.3 logE coated on each side thereof, said at least two silver halide emulsion layers being each sensitive to the same region of the electromagnetic spectrum, and (ii) an intensifying screen comprising a light emitting phosphors selected to have a radiation light emission having an emission maximum wavelength corresponding to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive, and (b) developing said exposed radiographic element.
- Figure 1 represents the optimal sensitometric curve for obtaining good imaging information in both regions of low and high X-ray absorption, in particular in the chest area in comparison with a standard sensitometric curve.
- This invention relates to a double side radiographic element which comprises a support and at least two silver halide emulsion layers coated on each side of said support, wherein said at least two silver halide emulsion layers show a speed difference of at least 0.3 logE and are both sensitive to the same region of the electromagnetic spectrum, and wherein said double side radiographic element shows a sensitometric curve having a toe contrast value higher than 0.45 and an average contrast higher than 1.40.
- the double side radiographic element comprises at least two silver halide emulsions having a difference in speed, measured at density 1.0 above minimum density, of at least 0.3 logE.
- the silver halide emulsion having the higher speed and the silver halide emulsion having the lower speed will be herein defined as the "high speed emulsion” and the “low speed emulsion”, respectively.
- the first and the second emulsion exhibit a speed difference in the range of from 0.3 to 1.0 logE, optimally from 0.4 to 0.8 logE. It should be understood that, although in a preferred aspect of the present invention the low speed emulsion is first coated on the support, and the high speed emulsion is coated on the low speed emulsion, the order of the coating could be inverted by a man skilled in the art, without the loss of the benefits of the present invention.
- the contrast is the density difference divided by the log of the difference in exposure levels at two density reference points on the characteristic curve, where the exposure levels are meter-candle-seconds. Accordingly, the contrast y can be measured with the following formula (I): wherein AD is the density difference and ⁇ LogE is the difference in speed between the density reference points.
- the average contrast is measured at density 0.25 and 2.00 above minimum density.
- the radiographic film of the present invention provides an average contrast, measured with the above mentioned formula (I), higher than 1.40, preferably higher than 1.50.
- the toe contrast value simply represents the speed difference (i.e., ALogE) obtained measuring the speed at 0.25 and 1.00 above minimum density.
- the radiographic film of the present invention shows a toe contrast value higher than 0.45, preferably higher than 0.55.
- the higher the toe contrast value (which represents the ⁇ LogE of the two density reference points), the lower the contrast measured with the above mentioned formula (I).
- the speed difference of the emulsions coated on the radiographic support should differ of at least 0.3 LogE, preferably of from 0.3 to 1.0 logE, optimally of from 0.4 to 0.8 logE.
- the average contrast of the emulsions coated on the radiographic support should also differ from each other.
- the contrast of the high speed emulsion and the low speed emulsion should differ by at least 0.2, more preferably by at least 0.3.
- the low speed emulsion shows an average contrast in the range of from 2.4 to 3.2, more preferably from 2.6 to 3.0
- the high speed emulsion shows an average contrast in the range of from 1.8 to 2.6, more preferably from 2.0 to 2.4.
- the best results are obtained when the high and low speed emulsions show the lower and higher contrast, respectively.
- electromagnetic spectrum refers to radiations having a wavelength of from 300 to 1200 nm, i.e., comprising the ultraviolet, visible and infrared radiations.
- the silver halide grains in the radiographic emulsion may be regular grain having a regular crystal structure such as cubic, octahedral, and tetradecahedral, or a spherical or irregular crystal structure, or those having crystal defects such as twin planes, epitaxialisation, or those having a tabular form, or combinations thereof.
- cubic grains is intended to include substantially cubic grains, that is, silver halide grains which are regular cubic grains bounded by crystallographic faces (100), or which may have rounded edges and/or vertices or small faces (111), or may even be nearly spherical when prepared in the presence of soluble iodides or strong ripening agents, such as ammonia.
- the silver halide grains may be of any required composition for forming a negative silver image, such as silver chloride, silver bromide, silver chlorobromide, silver bromoiodide, silver bromochloroiodide, and the like.
- silver bromoiodide grains preferably silver bromoiodide grains containing about 0.1 to 15% moles of iodide ions, more preferably about 0.5 to 10% moles of iodide ions and still preferably silver bromoiodide grains having average grain sizes in the range from 0.2 to 3 ⁇ m, more preferably from 0.4 to 1.5 /1.m.
- Preparation of silver halide emulsions comprising cubic silver halide grains is described, for example, in Research Disclosure, Vol. 176, December 1978, Item 17643, Vol. 184, August 1979, Item 18431 and Vol 308, December 1989, Item 308119.
- the tabular silver halide grains contained in the silver halide emulsion layers of this invention have an average diameter to thickness ratio (often referred to in the art as aspect ratio) of at least 2:1, preferably 3:1 to 20:1, more preferably 3:1 to 10:1, and most preferably 3:1 to 8:1.
- Average diameters of the tabular silver halide grains suitable for use in this invention range from about 0.3 ⁇ m to about 5 ⁇ m, preferably 0.5 ⁇ m to 3 ⁇ m, more preferably 0.8 ⁇ m to 1.5 ⁇ m.
- the tabular silver halide grains suitable for use in this invention have a thickness of less than 0.4 /1 .m, preferably less than 0.3 ⁇ m and more preferably less than 0.2 /1 .m.
- the tabular silver halide grain characteristics described above can be readily ascertained by procedures well known to those skilled in the art.
- the term "diameter” is defined as the diameter of a circle having an area equal to the projected area of the grain.
- the term “thickness” means the distance between two substantially parallel main planes constituting the tabular silver halide grains. From the measure of diameter and thickness of each grain the diameter to thickness ratio of each grain can be calculated, and the diameter to thickness ratios of all tabular grains can be averaged to obtain their average diameter to thickness ratio.
- the average diameter to thickness ratio is the average of individual tabular grain diameter to thickness ratios. In practice, it is simpler to obtain an average diameter and an average thickness of the tabular grains and to calculate the average diameter to thickness ratio as the ratio of these two averages. Whatever the method used may be, the average diameter to thickness ratios obtained do not differ greatly.
- the silver halide emulsion layer containing tabular silver halide grains at least 15%, preferably at least 25%, and, more preferably, at least 50% of the silver halide grains are tabular grains having an average diameter to thickness ratio of not less than 3:1.
- Each of the above proportions, "15%”, “25%” and “50%” means the proportion of the total projected area of the tabular grains having an average diameter to thickness ratio of at least 3:1 and a thickness lower than 0.4 /1 .m, as compared to the projected area of all of the silver halide grains in the layer.
- halogen compositions of the silver halide grains can be used.
- Typical silver halides include silver chloride, silver bromide, silver chloroiodide, silver bromoiodide, silver chlorobromoiodide and the like.
- silver bromide and silver bromoiodide are preferred silver halide compositions for tabular silver halide grains with silver bromoiodide compositions containing from 0 to 10 mol% silver iodide, preferably from 0.2 to 5 mol% silver iodide, and more preferably from 0.5 to 1.5 mol% silver iodide.
- the halogen composition of individual grains may be homogeneous or heterogeneous.
- Silver halide emulsions containing tabular silver halide grains can be prepared by various processes known for the preparation of radiographic elements.
- Silver halide emulsions can be prepared by the acid process, neutral process or ammonia process, or in the presence of any other silver halide solvent.
- a soluble silver salt and a halogen salt can be reacted in accordance with the single jet process, double jet process, reverse mixing process or a combination process by adjusting the conditions in the grain formation, such as pH, pAg, temperature, form and scale of the reaction vessel, and the reaction method.
- a silver halide solvent such as ammonia, thioethers, thioureas, etc., may be used, if desired, for controlling grain size, form of the grains, particle size distribution of the grains, and the grain- growth rate.
- hydrophilic dispersing agents for the silver halides can be employed.
- Gelatin is preferred, although other colloidal materials such as gelatin derivatives, colloidal albumin, cellulose derivatives or synthetic hydrophilic polymers can be used as known in the art.
- Other hydrophilic materials useful known in the art are described, for example, in Research Disclosure, Vol. 308, Item 308119, Section IX.
- highly deionized gelatin is used. The highly deionized gelatin is characterized by a higher deionization with respect to the commonly used photographic gelatins.
- the gelatin for use in the present invention is almost completely deionized which is defined as meaning that it presents less than 50 ppm (parts per million) of Call ions and is practically free (less than 5 parts per million) of other ions such as chlorides, phosphates, sulfates and nitrates, compared with commonly used photographic gelatins having up to 5,000 ppm of Call ions and significant presence of other ions.
- the highly deionized gelatin can be employed not only in the silver halide emulsion layers, but also in other component layers of the radiographic element, such as overcoat layers, interlayers and layers positioned beneath the emulsion layers.
- preferably at least 50%, more preferably at least 70% of the total hydrophilic colloid of the radiographic element comprises highly deionized gelatin.
- the amount of gelatin employed in the radiographic element of the present invention is such as to provide a total silver to gelatin ratio higher than 1 (expressed as grams of Ag/grams of gelatin).
- the silver to gelatin ratio of the silver halide emulsion layers is in the range of from 1 to 1.5.
- the radiographic element of the present invention can be forehardened to provide a good resistance in rapid processing conducted in automatic processing machine without the use of hardeners in processing solutions.
- gelatin hardeners are aldehyde hardeners, such as formaldehyde, glutaraldehyde and the like, active halogen hardeners, such as 2,4-dichloro-6-hydroxy-1,3,5-triazine, 2-chloro-4,6-hydroxy-1,3,5-triazine and the like, active vinyl hardeners, such as bis-vinylsulfonyl-methane, 1,2-vinylsulfonyl- ethane, bis-vinylsulfonyl-methyl ether, 1,2-bis-vinylsulfonylethyl ether and the like, N-methylol hardeners, such as dimethylolurea, methyloldimethyl hydantoin and the like, and bi-,tri-,or tetra-viny
- gelatin hardeners may be incorporated in the silver halide emulsion layer or in a layer of the silver halide radiographic element having a water-permeable relationship with the silver halide emulsion layer.
- the gelatin hardeners are incorporated in the silver halide emulsion layer.
- the amount of the above described gelatin hardener that is used in the silver halide emulsion of the radiographic element of this invention can be widely varied.
- the gelatin hardener is used in amounts of from 0.5% to 10% by weight of hydrophilic dispersing agent, such as the above described highly deionized gelatin, although a range of from 1% to 5% by weight of hydrophilic dispersing agent is preferred.
- the gelatin hardeners can be added to the silver halide emulsion layer or other component layers of the radiographic element utilizing any of the well-known techniques in emulsion making. For example, they can be dissolved in either water or a water-miscible solvent such as methanol, ethanol, etc. and added into the coating composition for the above mentioned silver halide emulsion layer or auxiliary layers.
- the silver halide emulsions can be chemically and optically sensitized by known methods.
- Spectral sensitization can be performed with a variety of spectral sensitizing dyes known in the art.
- An example of such spectral sensitizing dyes is the polymethine dye class, including cyanines, complex cyanines, merocyanines, complex merocyanines, oxonols, hemioxonols, styryls, merostyryls and streptocyanines.
- spectral sensitizing dyes according to this invention are those which exhibit J aggregates if adsorbed on the surface of the silver halide grains and a sharp absorption band (J-band) with a bathocromic shift with respect to the absorption maximum of the free dye in aqueous solution.
- J-band absorption band
- Spectral sensitizing dyes producing J aggregates are well known in the art, as illustrated by F. M. Hamer, Cyanine Dyes and Related Compounds, John Wiley and Sons, 1964, Chapter XVII and by T. H. James, The Theory of the Photographic Process, 4th edition, Macmillan, 1977, Chapter 8.
- the use of J-band exhibiting dyes allows the reduction of the well-known problem of crossover.
- J-band exhibiting dyes are cyanine dyes.
- Such dyes comprise two basic heterocyclic nuclei joined by a linkage of methine groups.
- the heterocyclic nuclei preferably include fused benzene rings to enhance J aggregation.
- the heterocyclic nuclei are preferably quinolinium, benzoxazolium, benzothiazolium, benzoselenazolium, benzimidazolium, naphthoxazolium, naphthothiazolium and naphthoselenazolium quaternary salts.
- J-band type dyes preferably used in the present invention have the following general formula (I): wherein
- the silver halide emulsions are spectrally sensitized to the green portion of the electromagnetic spectrum with a spectral sensitizing dye adsorbed on said silver halide grains represented by the following general formula (II): wherein
- the aryl groups included in said substituents R 6 , R 7 , R 8 and Rg each preferably contain from 6 to 18, more preferably from 6 to 10 carbon atoms, the total number of carbon atoms included in said groups arriving up to 20 carbon atoms.
- J-band sensitizing dyes belonging to those represented by the general formula (II) above:
- the silver halide emulsion layers can contain other constituents generally used in photographic products, such as binders, hardeners, surfactants, speed-increasing agents, stabilizers, plasticizers, gelatin extenders, optical sensitizers, dyes, ultraviolet absorbers, etc., and reference to such constituents can be found, for example, in Research Disclosure, Vol. 176, December 1978, Item 17643, Vol. 184, August 1979, Item 18431 and Vol 308, December 1989, Item 308119.
- the radiographic element of this invention can be prepared by coating the light-sensitive silver halide emulsion layers and other auxiliary layers on a support.
- materials suitable for the preparation of the support include glass, paper, polyethylene-coated paper, metals, polymeric film such as cellulose nitrate, cellulose acetate, polystyrene, polyethylene terephthalate, polyethylene, polypropylene and other well known supports.
- the silver halide emulsion layers are coated on the support at a total silver coverage of at least 1 g/m 2 , preferably in the range of from 2 to 5 g/m 2 .
- Auxiliary layers can be represented by top-coating layers, antistatic layers, antihalo layer, protective layers, dye underlayers, and the like.
- Dye underlayers are particularly useful in order to reduce the crossover of the double coated silver halide radiographic material of the present invention.
- Reference to well-known dye underlayer can be found in US 4,900,652, US 4,855,221, US 4,857,446, 4,803,150.
- a dye underlayer is coated on at least one side of the support, more preferably on both sides of the support, before the coating of said at least two silver halide emulsions.
- this invention relates to a symmetrical radiographic assembly comprising:
- symmetrical radiographic assembly refers to a radiographic assembly which comprises a silver halide double coated radiographic element comprising substantially identical silver halide emulsion layers coated on each side of the support, said radiographic element being interposed between a pair of intensifying screens.
- the radiographic element according to the present invention is associated with the intensifying screens so as to be exposed to the radiations emitted by said screens.
- the pair of screens employed in combination with the radiographic element of the present invention is symmetrical.
- the screens are made of relatively thick phosphor layers which transform the x-rays into light radiation (e. g., visible light).
- the screens absorb a portion of x-rays much larger than the radiographic element and are used to reduce the radiation dose necessary to obtain a useful image.
- the phosphors used in the intensifying screens applied in the present invention have an emission maximum wavelength in the ultraviolet, blue, green, red or infrared region of the electromagnetic spectrum according to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive. More preferably, said phosphors emit radiations in the ultraviolet, blue and green regions of the electromagnetic spectrum.
- Green emitting phosphors emit radiation having more than about 80% of its spectral emission above 480 nm and its maximum of emission in the wavelength range of 530-570 nm.
- Green emitting phosphors which may be used in the intensifying screens of the present invention include rare earth activated rare earth oxysulfide phosphors of at least one rare earth element selected from yttrium, lanthanum, gadolinium and lutetium, rare earth activated rare earth oxyhalide phosphors of the same rare earth elements, a phosphor composed of a borate of the above rare earth elements, a phosphor composed of a phosphate of the above rare earth elements and a phosphor composed of tantalate of the above rare earth elements.
- rare earth green emitting phosphors have been extensively described in the patent literature, for example in US Patents 4,225,653, 3,418,246, 3,418,247, 3,725,704, 3,617,743, 3,974,389, 3,591,516, 3,607,770, 3,666,676, 3,795,814, 4,405,691, 4,311,487 and 4,387,141.
- These rare earth phosphors have a high X-ray absorbing power and high efficiency of light emission when excited with X radiation and enable radiologists to use substantially lower X radiation dosage levels.
- Particularly suitable phosphors for use in the intensifying screens of the present invention are terbium or terbium-thulium activated rare earth oxysulfide phosphors represented by the following general formula: wherein Ln is at least one rare earth element selected from lanthanum, gadolinium and lutetium, and a and b are numbers such as to meet the conditions 0.0005 ⁇ a 0.09 and 0 ⁇ b ⁇ 0.01, respectively, and terbium or terbium-thulium activated rare earth oxysulfide phosphors represented by the following general formula: wherein Ln is at least one rare earth element selected from lanthanum, gadolinium and lutetium, and a, b and c are numbers such as to meet the conditions 0.0005 ⁇ a ⁇ 0.09, 0 ⁇ b ⁇ 0.01 and 0.65 ⁇ c ⁇ 0.95, respectively.
- UV-blue emitting phosphors emit radiation having more than about 80% of their spectral emission below 450 nm and their maximum of emission in the wavelength range of 300-400 nm.
- UV-blue emitting phosphors which may be used in the intensifying screens of the present invention include UV-blue emitting phosphors known in the art such as lead or lanthanum activated barium sulfate phosphors, barium fluorohalide phosphors, lead activated barium silicate phosphors, gadolinium activated yttrium oxide phosphors, barium fluoride phosphors, alkali metal activated rare earth niobate or tantalate phosphors etc.
- UV-blue emitting phosphors are described for example in BE 703,998 and 757,815, in EP 202,875 and by Buchanan et al., J. Applied Physics, vol. 9, 4342-4347, 1968,and by Clapp and Ginther, J. of the Optical Soc. of America, vol. 37, 355-362,1947.
- Particularly suitable UV-blue emitting phosphors for use in the intensifying screens of the present invention are those represented by the following general formula: wherein x and y are numbers such as to meet the conditions 10- 5 ⁇ x 1 1 and 10- 4 ⁇ y 0.1 as described in EP 202,875.
- the intensifying screens of this invention have a fluorescent layer comprising a binder and at least one phosphor dispersed therein.
- the fluorescent layer is formed by dispersing the phosphor(s) in the binder to prepare a coating dispersion having the desired phosphor weight ratio, and then applying the coating dispersion by a conventional coating method to form a uniform layer.
- the fluorescent layer itself can be an intensifying screen when the fluorescent layer is self-supporting, the fluorescent layer is generally provided on a substrate to form an intensifying screen.
- a protective layer for physically and chemically protecting the fluorescent layer is usually provided on the surface of the fluorescent layer.
- a primer layer is sometimes provided between the fluorescent layer and the substrate to closely bond the fluorescent layer to the substrate, and a reflective layer is sometimes provided between the substrate (or the primer) and the fluorescent layer.
- the binder employed in the fluorescent layer of the intensifying screens of the present invention can be, for example, one of the binders commonly used in forming layers: gum arabic, protein such as gelatin, polysaccharides such as dextran, organic polymer binders such as polyvinylbutyral, polyvinylacetate, nitrocellulose, ethylcellulose, vinylidene-chloride-vinylchloride copolymer, polymethylmethacrylate, polybutylmethacrylate, vinylchloride-vinylacetate copolymer, polyurethane, cellulose acetate butyrate, polyvinyl alcohol, and the like.
- binders commonly used in forming layers: gum arabic, protein such as gelatin, polysaccharides such as dextran, organic polymer binders such as polyvinylbutyral, polyvinylacetate, nitrocellulose, ethylcellulose, vinylidene-chloride-vinylchloride copolymer, polymethylmeth
- the binder is used in an amount of 0.01 to 1 part by weight per one part by weight of the phosphor.
- the amount of the binder should preferably be small. Accordingly, in consideration of both the sensitivity and the sharpness of the screen and the easiness of application of the coating dispersion, the binder is preferably used in an amount of 0.03 to 0.2 parts by weight per one part by weight of the phosphor.
- the thickness of the fluorescent layer is generally within the range of 10 ⁇ m to 1 mm.
- the fluorescent layer is generally coated on a substrate.
- the substrate various materials such as polymeric material, glass, wool, cotton, paper, metal, or the like can be used. From the viewpoint of handling the screen, the substrate should preferably be processed into a sheet or a roll having flexibility.
- the substrate is preferably either a plastic film (such as a cellulose triacetate film, polyester film, polyethylene terephthalate film, polyamide film, polycarbonate film, or the like), or ordinary paper or processed paper (such as a photographic paper, baryta paper, resin-coated paper, pigment-containing paper which contains a pigment such as titanium dioxide, or the like).
- the substrate may have a primer layer on one surface thereof (the surface on which the fluorescent layer is provided) for the purpose of holding the fluorescent layer tightly.
- a primer layer on one surface thereof (the surface on which the fluorescent layer is provided) for the purpose of holding the fluorescent layer tightly.
- an ordinary adhesive can be used as the material of the primer layer.
- a coating dispersion comprising the phosphor dispersed in a binder may be directly applied to the substrate (or to the primer layer or to the reflective layer).
- a protective layer for physically and chemically protecting the fluorescent layer is generally provided on the surface of the fluorescent layer intended for exposure (on the side opposite the substrate).
- the protective layer may be provided on both surfaces of the fluorescent layer.
- the protective layer may be provided on the fluorescent layer by directly applying thereto a coating dispersion to form the protective layer thereon, or may be provided thereon by bonding thereto the protective layer formed beforehand.
- a conventional material for a protective layer such a nitrocellulose, ethylcellulose, cellulose acetate, polyester, polyethyleneterephthalate, and the like can be used.
- the intensifying screens of the present invention may be colored with a dye. Further, the fluorescent layer may contain a white powder dispersed therein. By using a dye or a white powder, an intensifying screen which provides an image of high sharpness can be obtained.
- the present invention relates to a process for obtaining a radiographic image
- a process for obtaining a radiographic image comprising the step of (a) image-wise exposing to an X-ray radiation which has passed through an object (particularly an animal or human body for medical radiographic imaging), a symmetrical radiographic assembly comprising (i) a double side radiographic element having a support and at least two silver halide emulsion layers having a speed difference of at least 0.3 logE coated on each side thereof, said at least two silver halide emulsion layers being each sensitive to the same region of the electromagnetic spectrum, and (ii) an intensifying screen comprising a light emitting phosphors selected to have a radiation light emission having an emission maximum wavelength corresponding to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive, and (b) developing said exposed radiographic element.
- the radiographic elements of this invention in the silver halide emulsion layers or in other layers, can include additional addenda of conventional nature, such as stabilizers, antifoggants, brighteners, absorbing materials, hardeners, coating aids, plasticizers, lubricants, mating agents, antikinking agents, antistatic agents, and the like, as described in Research Disclosure, Vol. 176, December 1978, Item 17643, in Research Disclosure, Vol. 184, August 1979 Item 18431, and in Research Disclosure, Vol. 308, December 1989, Item 308119.
- additional addenda of conventional nature such as stabilizers, antifoggants, brighteners, absorbing materials, hardeners, coating aids, plasticizers, lubricants, mating agents, antikinking agents, antistatic agents, and the like, as described in Research Disclosure, Vol. 176, December 1978, Item 17643, in Research Disclosure, Vol. 184, August 1979 Item 18431, and in Research Disclosure, Vol. 308, December 1989,
- Stabilizers antifogging and antifolding agents.
- An octahedral silver bromochloroiodide emulsion (Em. A) containing 84.4%M bromide, 14.4%M chloride and 1.2%M iodide was sulfur and gold chemically sensitized with gold thiocyanate complex, sodium p-toluenethiosulfonate,sodium p-toluenesulfinate and benzo-thiazoleiodoethylate, spectrally sensitized with the green sensitizing dye anhydro-5,5'-dichloro-9-ethyl-3,3'-bis-(3-sulfopropyl)-oxacarbocyanine hydroxide triethylamine salt, and added with resorcylaldehyde and dimethylol urea hardeners.
- the silver halide grains have an average crystal diameter of 0.7 ⁇ m.
- a tabular silver bromoiodide emulsion (Em. B) containing 99.4%M bromide and 0.6%M iodide was chemically and spectrally sensitized as the above described emulsion A.
- the tabular silver halide grains have an average diameter of 1.35 ⁇ m, an average thickness of 0.25 ⁇ m and an aspect ratio of 5.4.
- Emulsion A and B show a difference in speed of about 0.5 logE.
- Emulsion A was coated as first emulsion layer on both sides of a 0,18mm blue polyester film at a silver coating weight of 1.3 g/m 2 on each side.
- An emulsion blend was prepared by mixing equal parts (based on silver content) of emulsion A and B. This emulsion blend was coated over the first emulsion layer on both sides of the film at a silver coating weight of 1.0 g/m 2. On both emulsion layers was applied a gelatin top coat with a gelatin thickness of 0.9 ⁇ m.
- Emulsion A was coated as first emulsion layer on both sides of a 0,18mm blue polyester film at a silver coating weight of 1.5 g/m 2 on each side.
- Emulsion B was coated over the first emulsion layer on both sides of the film at a silver coating weight of 1.0 g/m 2.
- a gelatin top coat On both emulsion layers was applied a gelatin top coat with a gelatin thickness of 0.9 ⁇ m.
- TrimaxTM T6 screen is a medium resolution screen manufactured by 3M Company, comprising a terbium activated gadolinium oxysulfide phosphor having an average particle size of 3.5 ⁇ m coated in a hydrophobic polymer binder at a phosphor coverage of 500 g/m 2 and a thickness of 139 ⁇ m on a polyester support.
- TrimaxTM T8 screen is a medium resolution screen manufactured by 3M Company, comprising a green emitting terbium activated gadolinium oxysulfide phosphor having an average particle size of 8.2 ⁇ m coated in a hydrophobic polymer binder at a phosphor coverage of 420 g/m 2 and a thickness of 105 ⁇ m on a polyester support.
- TrimaxTM T16 screen is a high speed screen manufactured by 3M Company, comprising a terbium activated gadolinium oxysulfide phosphor having an average particle size of 5.5 ⁇ m coated in a hydrophobic polymer binder at a phosphor coverage of 1050 g/m 2 and a thickness of 250 ⁇ m on a polyester support.
- 3M XLATM Radiographic Film is a conventional radiographic film having extended latitude
- Kodak InsightTM Chest Film is an unsimmetrical radiographic film having an emulsion layer with high contrast and low speed on one side and an emulsion layer with low contrast and high speed on the other side.
- the exposed films were processed in a 3M Trimatic TM XP515 automatic processor at a total processing time of 90 seconds using the developer and fixer having the following composition.
- Tables 1 and 2 clearly show the improvement in terms of toe contrast value and average contrast of the films 1 and 2 of the present invention, which can provide a sensitometric curve very similar to the ideal curve of Fig.1.
- the Kodak InsightTM Film has an unsimmetrical structure, as described in the above mentioned US 4,994,355, and accordingly, it requires a specific orientation in order to work well.
- table 1 and 2 clearly show that the Kodak InsightTM Film also provides different results with different screens in terms of average contrast and toe contrast value.
- both Films 1 and 2 maintain the same sensitometric characteristics even if the screen combination is changed or reversed.
- the radiographic film of the present invention does not require a specific care by the operator having regards the orientation and/or the kind of intensifying screens, and accordingly can be more easily handled than the prior art chest radiographic films.
Abstract
Description
- The present invention relates to a combination of photosensitive elements for use in radiography. More specifically, the present invention relates to a double-side coated silver halide radiographic element for use in medical radiography, preferably for chest diagnostic imaging, and to the combination thereof with a pair of fluorescent phosphor screens.
- It is known in the art of medical radiography to employ intensifying screens to reduce the X-ray dosage to the patient. Intensifying screens absorb the X-ray radiation and emit electromagnetic radiations which can be better absorbed by silver halide emulsion layers. Another approach to reduce the X-ray dosage to the patient is to coat two silver halide emulsion layers on the opposite sides of a support to form a duplitized radiographic element.
- Accordingly, it is a common practice in medical radiography to use a radiographic assembly consisting of a duplitized radiographic element interposed between a pair of front and back screens.
- One of the problems of medical radiography relates to the different X-ray absorption of the various parts of the body. For example, in chest radiography the heart area has an absorption ten times higher than the lung area. A similar effect occurs in the radiography of the stomach, where a contrast medium is used in order to enhance the image depictivity (the part of the body having no contrast medium being totally black), and of hands and legs, where bones have an X-ray absorption higher than that of soft tissues such as flesh and cartilage.
- In these cases a radiographic element showing a low contrast is required for an area of high X-ray absorption and a radiographic element showing a high contrast is required for an area of low X-ray absorption. The resulting film is a compromise in an attempt to have sufficient optical density and sharpness for these different areas of the body. In the art of chest radiography, X-ray images providing visually discernible features in both the heart and lung image areas are attempted by using extended latitude radiographic elements. Extended latitude radiographic elements typically employ polydispersed silver halide emulsions to provide lower average contrasts and a wider range of exposures separating minimum and maximum density exposures. Said extended latitude radiographic elements, however, do not provide the desired sensitometric curve necessary to obtain visually useful imaging details in both heart and lung areas. The optimal sensitometric curve for obtaining good imaging information in both regions of low and high X-ray absorption is shown in Fig. 1. Various methods have been suggested to solve the problem of needing different contrast capabilities for different areas of the body. One approach relates to the use of double coated radiographic elements having a different emulsion layer coated on each side of the support. An example of this solution can be found in FR 1,103,973, wherein the use of screens having a light emission ratio of from 1:1 to 1.5:1 (back screen:front screen) in combination with a radiographic element having coated thereon a high contrast back emulsion and a low contrast front emulsion is suggested. A combination of screens having a light emission ratio higher than 1.5:1 and radiographic elements having emulsion layers with the same gradation is also suggested. Other patents disclose the use of double coated radiographic elements having emulsion layers with different contrast or sensitivity. For example, DE 1,017,464 discloses a double coated radiographic element having coated thereon a first emulsion with high sensitivity and low contrast and a second emulsion with low sensitivity and high contrast, FR 885,707 discloses a double coated radiographic element having coated thereon a first high speed emulsion and a second high contrast emulsion, and FR 875,269 discloses a radiographic assembly comprising several radiographic films or papers, each having a different sensitivity and/or contrast relative to the others, in order to obtain separate and different images of the same object with a single exposure. Nothing in the above described patents suggests the use of specific features to obtain a symmetric double-coated radiographic element showing the sensitometric curve of Fig. 1. An approach similar to that of the above described French and German patents is disclosed in US 4,994,355, claiming an unsymmetrical double coated radiographic element having emulsion layers with different contrast, in US 4,997,750, claiming an unsymmetrical double coated radiographic element having emulsion layers with different sensitivity, and in US 5,021,327 claiming an unsymmetrical radiographic assembly wherein the back screen and emulsion layer have a photicity at least twice that of the front screen and emulsion layer, the photicity being defined as the integrated product of screen emission and emulsion sensitivity. All these proposed solutions require the use of an unsymmetrical radiographic film which requires a specific orientation relative to the screens for a proper use.
- The following are additional documents illustrating the state of the art.
- FR 787,017 discloses a radiographic element comprising silver halide emulsion layers of different color sensitivity to be combined with intensifying screens emitting radiation to which the silver halides are sensitive. The purpose of this patent is to obtain an increased use of radiation.
- EP 88,820 discloses a radiographic fluorescent screen comprising a first blue emitting phosphor layer and a second green emitting phosphor layer to be combined with a silver halide element having spectral sensitivity in the blue-green region ("ortho-type" elements).
- JP 60-175000 discloses a combination of a double coated silver halide element and a screen pair wherein the fluorescent layers of the two screens have different wavelength region emissions and each screen comprises an organic dye to absorb the light emitted by the opposite screen.
- EP 350,883 discloses a technique for crossover reduction in which silver halide emulsion layers having different color sensitivities are provided on the opposite sides of a transparent support, and X-ray fluorescent intensifying screens having emission spectra corresponding to the respective color sensitivities are used.
- Research Disclosure, December 1973, Vol. 116, Item 11620 discloses a radiographic element which shows different contrast when observed with or without a green filter, respectively.
- Finally, EP 126,644 describes a radiographic material having a characteristic curve whose gamma between optical densities of 0.50 and 1.50 is 2.7 to 3.3 and gamma between optical densities of 2.00 and 3.00 is 1.5 to 2.5, said material having a wide exposure latitude to make possible the production of images having high diagnostic ability.
- This invention relates to a double side radiographic element which comprises a support and at least two silver halide emulsion layers coated on each side of said support, wherein said at least two silver halide emulsion layers show a speed difference of at least 0.3 logE and are both sensitive to the same region of the electromagnetic spectrum, and wherein said double side radiographic element shows a sensitometric curve having a toe contrast value higher than 0.45 and an average contrast higher than 1.40.
- In another aspect this invention relates to a symmetrical radiographic assembly comprising:
- - a double side radiographic element which comprises a support and hydrophilic colloid layers coated on each side of said support, and
- - an intensifying screen adjacent to each side of said radiographic element,
- wherein on each side of said support are coated at least two silver halide emulsion layers having a speed difference of at least 0.3 logE, said at least two silver halide emulsion layers being each sensitive to the same region of the electromagnetic spectrum,
- wherein said intensifying screen comprises a light emitting phosphor selected to have a radiation light emission having an emission maximum wavelength corresponding to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive, and
- wherein said double side radiographic element shows a sensitometric curve having a toe contrast value higher than 0.45 and an average contrast higher than 1.40.
- In a further aspect, the present invention relates to a process for obtaining a radiographic image comprising the step of (a) image-wise exposing to an X-ray radiation which has passed through an object, a symmetrical radiographic assembly comprising (i) a double side radiographic element having a support and at least two silver halide emulsion layers having a speed difference of at least 0.3 logE coated on each side thereof, said at least two silver halide emulsion layers being each sensitive to the same region of the electromagnetic spectrum, and (ii) an intensifying screen comprising a light emitting phosphors selected to have a radiation light emission having an emission maximum wavelength corresponding to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive, and (b) developing said exposed radiographic element.
- Figure 1 represents the optimal sensitometric curve for obtaining good imaging information in both regions of low and high X-ray absorption, in particular in the chest area in comparison with a standard sensitometric curve.
- This invention relates to a double side radiographic element which comprises a support and at least two silver halide emulsion layers coated on each side of said support, wherein said at least two silver halide emulsion layers show a speed difference of at least 0.3 logE and are both sensitive to the same region of the electromagnetic spectrum, and wherein said double side radiographic element shows a sensitometric curve having a toe contrast value higher than 0.45 and an average contrast higher than 1.40.
- According to the present invention, the double side radiographic element comprises at least two silver halide emulsions having a difference in speed, measured at density 1.0 above minimum density, of at least 0.3 logE.
- The silver halide emulsion having the higher speed and the silver halide emulsion having the lower speed will be herein defined as the "high speed emulsion" and the "low speed emulsion", respectively.
- While the best choice of speed difference between the low speed emulsion and the high speed emulsion can differ widely, depending upon the application to be served, in most instances the first and the second emulsion exhibit a speed difference in the range of from 0.3 to 1.0 logE, optimally from 0.4 to 0.8 logE. It should be understood that, although in a preferred aspect of the present invention the low speed emulsion is first coated on the support, and the high speed emulsion is coated on the low speed emulsion, the order of the coating could be inverted by a man skilled in the art, without the loss of the benefits of the present invention.
- As known in the photographic art, the contrast is the density difference divided by the log of the difference in exposure levels at two density reference points on the characteristic curve, where the exposure levels are meter-candle-seconds. Accordingly, the contrast y can be measured with the following formula (I):
- On the contrary, the toe contrast value simply represents the speed difference (i.e., ALogE) obtained measuring the speed at 0.25 and 1.00 above minimum density. The radiographic film of the present invention shows a toe contrast value higher than 0.45, preferably higher than 0.55. In this case, the higher the toe contrast value (which represents the ΔLogE of the two density reference points), the lower the contrast measured with the above mentioned formula (I).
- In order to obtain such values of average contrast and toe contrast, the speed difference of the emulsions coated on the radiographic support should differ of at least 0.3 LogE, preferably of from 0.3 to 1.0 logE, optimally of from 0.4 to 0.8 logE. According to a preferred embodiment of the present invention the average contrast of the emulsions coated on the radiographic support should also differ from each other. The contrast of the high speed emulsion and the low speed emulsion should differ by at least 0.2, more preferably by at least 0.3. According to a more preferred embodiment of the present invention the low speed emulsion shows an average contrast in the range of from 2.4 to 3.2, more preferably from 2.6 to 3.0, and the high speed emulsion shows an average contrast in the range of from 1.8 to 2.6, more preferably from 2.0 to 2.4. Generally, the best results are obtained when the high and low speed emulsions show the lower and higher contrast, respectively.
- As employed herein the term "electromagnetic spectrum" refers to radiations having a wavelength of from 300 to 1200 nm, i.e., comprising the ultraviolet, visible and infrared radiations.
- The silver halide grains in the radiographic emulsion may be regular grain having a regular crystal structure such as cubic, octahedral, and tetradecahedral, or a spherical or irregular crystal structure, or those having crystal defects such as twin planes, epitaxialisation, or those having a tabular form, or combinations thereof.
- The term "cubic grains" according to the present invention is intended to include substantially cubic grains, that is, silver halide grains which are regular cubic grains bounded by crystallographic faces (100), or which may have rounded edges and/or vertices or small faces (111), or may even be nearly spherical when prepared in the presence of soluble iodides or strong ripening agents, such as ammonia. The silver halide grains may be of any required composition for forming a negative silver image, such as silver chloride, silver bromide, silver chlorobromide, silver bromoiodide, silver bromochloroiodide, and the like. Particularly good results are obtained with silver bromoiodide grains, preferably silver bromoiodide grains containing about 0.1 to 15% moles of iodide ions, more preferably about 0.5 to 10% moles of iodide ions and still preferably silver bromoiodide grains having average grain sizes in the range from 0.2 to 3 µm, more preferably from 0.4 to 1.5 /1.m. Preparation of silver halide emulsions comprising cubic silver halide grains is described, for example, in Research Disclosure, Vol. 176, December 1978, Item 17643, Vol. 184, August 1979, Item 18431 and Vol 308, December 1989, Item 308119.
- Other silver halide emulsions according to this invention having highly desirable imaging characteristics are those which employ one or more light-sensitive tabular grain emulsions as disclosed in US Patents 4,425,425 and 4,425,426. The tabular silver halide grains contained in the silver halide emulsion layers of this invention have an average diameter to thickness ratio (often referred to in the art as aspect ratio) of at least 2:1, preferably 3:1 to 20:1, more preferably 3:1 to 10:1, and most preferably 3:1 to 8:1. Average diameters of the tabular silver halide grains suitable for use in this invention range from about 0.3 µm to about 5 µm, preferably 0.5 µm to 3 µm, more preferably 0.8 µm to 1.5 µm. The tabular silver halide grains suitable for use in this invention have a thickness of less than 0.4 /1.m, preferably less than 0.3 µm and more preferably less than 0.2 /1.m.
- The tabular silver halide grain characteristics described above can be readily ascertained by procedures well known to those skilled in the art. The term "diameter" is defined as the diameter of a circle having an area equal to the projected area of the grain. The term "thickness" means the distance between two substantially parallel main planes constituting the tabular silver halide grains. From the measure of diameter and thickness of each grain the diameter to thickness ratio of each grain can be calculated, and the diameter to thickness ratios of all tabular grains can be averaged to obtain their average diameter to thickness ratio. By this definition the average diameter to thickness ratio is the average of individual tabular grain diameter to thickness ratios. In practice, it is simpler to obtain an average diameter and an average thickness of the tabular grains and to calculate the average diameter to thickness ratio as the ratio of these two averages. Whatever the method used may be, the average diameter to thickness ratios obtained do not differ greatly.
- In the silver halide emulsion layer containing tabular silver halide grains, at least 15%, preferably at least 25%, and, more preferably, at least 50% of the silver halide grains are tabular grains having an average diameter to thickness ratio of not less than 3:1. Each of the above proportions, "15%", "25%" and "50%" means the proportion of the total projected area of the tabular grains having an average diameter to thickness ratio of at least 3:1 and a thickness lower than 0.4 /1.m, as compared to the projected area of all of the silver halide grains in the layer.
- As described above, commonly employed halogen compositions of the silver halide grains can be used. Typical silver halides include silver chloride, silver bromide, silver chloroiodide, silver bromoiodide, silver chlorobromoiodide and the like. However, silver bromide and silver bromoiodide are preferred silver halide compositions for tabular silver halide grains with silver bromoiodide compositions containing from 0 to 10 mol% silver iodide, preferably from 0.2 to 5 mol% silver iodide, and more preferably from 0.5 to 1.5 mol% silver iodide. The halogen composition of individual grains may be homogeneous or heterogeneous.
- Silver halide emulsions containing tabular silver halide grains can be prepared by various processes known for the preparation of radiographic elements. Silver halide emulsions can be prepared by the acid process, neutral process or ammonia process, or in the presence of any other silver halide solvent. In the stage for the preparation, a soluble silver salt and a halogen salt can be reacted in accordance with the single jet process, double jet process, reverse mixing process or a combination process by adjusting the conditions in the grain formation, such as pH, pAg, temperature, form and scale of the reaction vessel, and the reaction method. A silver halide solvent, such as ammonia, thioethers, thioureas, etc., may be used, if desired, for controlling grain size, form of the grains, particle size distribution of the grains, and the grain- growth rate.
- Preparation of silver halide emulsions containing tabular silver halide grains is described, for example, in de Cugnac and Chateau, "Evolution of the Morphology of Silver Bromide Crystals During Physical Ripening", Science and Industries Photographiques, Vol. 33, No.2 (1962), pp.121-125, in Gutoff, "Nucleation and Growth Rates During the Precipitation of Silver Halide Photographic Emulsions", Photographic Science and Engineering, Vol. 14, No. 4 (1970), pp. 248-257,in Berry et al., "Effects of Environment on the Growth of Silver Bromide Microcrystals", Vol.5, No.6 (1961), pp. 332-336, in US Pat. Nos. 4,063,951, 4,067,739, 4,184,878, 4,434,226, 4,414,310, 4,386,156, 4,414,306 and in EP Pat. Appln. No. 263,508.
- In preparing the silver halide emulsions of the present invention, a wide variety of hydrophilic dispersing agents for the silver halides can be employed. Gelatin is preferred, although other colloidal materials such as gelatin derivatives, colloidal albumin, cellulose derivatives or synthetic hydrophilic polymers can be used as known in the art. Other hydrophilic materials useful known in the art are described, for example, in Research Disclosure, Vol. 308, Item 308119, Section IX. In a preferred aspect of the present invention highly deionized gelatin is used. The highly deionized gelatin is characterized by a higher deionization with respect to the commonly used photographic gelatins. Preferably, the gelatin for use in the present invention is almost completely deionized which is defined as meaning that it presents less than 50 ppm (parts per million) of Call ions and is practically free (less than 5 parts per million) of other ions such as chlorides, phosphates, sulfates and nitrates, compared with commonly used photographic gelatins having up to 5,000 ppm of Call ions and significant presence of other ions.
- The highly deionized gelatin can be employed not only in the silver halide emulsion layers, but also in other component layers of the radiographic element, such as overcoat layers, interlayers and layers positioned beneath the emulsion layers. In the present invention, preferably at least 50%, more preferably at least 70% of the total hydrophilic colloid of the radiographic element comprises highly deionized gelatin. The amount of gelatin employed in the radiographic element of the present invention is such as to provide a total silver to gelatin ratio higher than 1 (expressed as grams of Ag/grams of gelatin). In particular the silver to gelatin ratio of the silver halide emulsion layers is in the range of from 1 to 1.5.
- The radiographic element of the present invention can be forehardened to provide a good resistance in rapid processing conducted in automatic processing machine without the use of hardeners in processing solutions. Examples of gelatin hardeners are aldehyde hardeners, such as formaldehyde, glutaraldehyde and the like, active halogen hardeners, such as 2,4-dichloro-6-hydroxy-1,3,5-triazine, 2-chloro-4,6-hydroxy-1,3,5-triazine and the like, active vinyl hardeners, such as bis-vinylsulfonyl-methane, 1,2-vinylsulfonyl- ethane, bis-vinylsulfonyl-methyl ether, 1,2-bis-vinylsulfonylethyl ether and the like, N-methylol hardeners, such as dimethylolurea, methyloldimethyl hydantoin and the like, and bi-,tri-,or tetra-vinylsulfonyl substituted organic hydroxy compounds, such as 1,3-bis-vinylsulfonyl-2-propanol and the like. Other useful gelatin hardeners may be found in Research Disclosure, Vol. 308, December 1989, Item 308119, Paragraph X.
- The above described gelatin hardeners may be incorporated in the silver halide emulsion layer or in a layer of the silver halide radiographic element having a water-permeable relationship with the silver halide emulsion layer. Preferably, the gelatin hardeners are incorporated in the silver halide emulsion layer.
- The amount of the above described gelatin hardener that is used in the silver halide emulsion of the radiographic element of this invention can be widely varied. Generally, the gelatin hardener is used in amounts of from 0.5% to 10% by weight of hydrophilic dispersing agent, such as the above described highly deionized gelatin, although a range of from 1% to 5% by weight of hydrophilic dispersing agent is preferred.
- The gelatin hardeners can be added to the silver halide emulsion layer or other component layers of the radiographic element utilizing any of the well-known techniques in emulsion making. For example, they can be dissolved in either water or a water-miscible solvent such as methanol, ethanol, etc. and added into the coating composition for the above mentioned silver halide emulsion layer or auxiliary layers.
- The silver halide emulsions can be chemically and optically sensitized by known methods.
- Spectral sensitization can be performed with a variety of spectral sensitizing dyes known in the art. An example of such spectral sensitizing dyes is the polymethine dye class, including cyanines, complex cyanines, merocyanines, complex merocyanines, oxonols, hemioxonols, styryls, merostyryls and streptocyanines.
- Although native UV-blue sensitivity of silver halides is usually known in the art, significant advantage can be obtained by the use of spectral sensitizing dyes, even when their principal absorption is in the spectral region to which the silver halide emulsion have their native sensitivity.
- Preferably, spectral sensitizing dyes according to this invention are those which exhibit J aggregates if adsorbed on the surface of the silver halide grains and a sharp absorption band (J-band) with a bathocromic shift with respect to the absorption maximum of the free dye in aqueous solution. Spectral sensitizing dyes producing J aggregates are well known in the art, as illustrated by F. M. Hamer, Cyanine Dyes and Related Compounds, John Wiley and Sons, 1964, Chapter XVII and by T. H. James, The Theory of the Photographic Process, 4th edition, Macmillan, 1977, Chapter 8. The use of J-band exhibiting dyes allows the reduction of the well-known problem of crossover.
- In a preferred form, J-band exhibiting dyes are cyanine dyes. Such dyes comprise two basic heterocyclic nuclei joined by a linkage of methine groups. The heterocyclic nuclei preferably include fused benzene rings to enhance J aggregation.
- The heterocyclic nuclei are preferably quinolinium, benzoxazolium, benzothiazolium, benzoselenazolium, benzimidazolium, naphthoxazolium, naphthothiazolium and naphthoselenazolium quaternary salts.
-
- Z1 and Z2 may be the same or different and each represents the elements necessary to complete a cyclic nucleus derived from basic heterocyclic nitrogen compounds such as oxazoline, oxazole, benzoxazole, the naphthoxazoles (e.g., naphth{2,1-d}oxazole, naphth-(2,3-d)-oxazole, and naphth-{1,2-d}-oxazole), thiazoline, thiazole, benzothiazole, the naphthothiazoles (e.g., naphtho{2,1-d}thiazo!e), the thiazoloquinolines (e.g., thiazolo{4,5-b}quinoline), selenazoline, selenazole, benzoselenazole, the naphthoselenazoles (e.g., naphtho{1,2-d}selenazole, 3H-indole (e.g., 3,3-dimethyl3H-indole), the benzindoles (e.g., 1,1-dimethylben- zindole), imidazoline, imidazole, benzimidazole, the naphthimidazoles (e.g., naphth-{2,3-d}-imidazole), pyridine, and quinoline, which nuclei may be substituted on the ring by one or more of a wide variety of substitutes such as hydroxy, the halogens (e.g., fluoro, bromo, chloro, and iodo), alkyl groups or substituted alkyl groups (e.g., methyl, ethyl, propyl, isopropyl, butyl, octyl, dodecyl, 2-hydroxyethyl, 3-sulfopropyl, carboxymethyl, 2-cyanoethyl, and trifluoromethyl), aryl groups or substituted aryl groups (e.g., phenyl, 1-naphthyl, 2-naphthyl, 4-sulfophenyl, 3-carboxyphenyl, and 4-biphenyl), aralkyl groups (e.g., benzyl and phenethyl), alkoxy groups (e.g., methoxy, ethoxy, and isopropoxy), aryloxy groups (e.g., phenoxy and 1-naphthoxy), alkylthio groups (e.g., ethylthio and methylthio), arylthio groups (e.g., phenylthio, p-tolylthio, and 2-naphthylthio), methylenedioxy, cyano, 2-thienyl, styryl, amino or substituted amino groups (e.g., anilino, dimethylanilino, diethylanilino, and morpholino), acyl groups (e.g., acetyl and benzoyl), and sulfo groups,
- R1 and R2 can be the same or different and represent alkyl groups, aryl groups, alkenyl groups, or aralkyl groups, with or without substitutes, (e.g., carboxymethyl, 2-hydroxyethyl, 3-sulfopropyl, 3-sulfobutyl, 4-sulfobutyl, 2-methoxyethyl, 2-sulfatoethyl, 3-thiosulfatoethyl, 2-phosphonoethyl, chlorophenyl, and bromophenyl),
- R3 represents a hydrogen atom,
- R4 and R5 can be the same or different and represent a hydrogen atom or a lower alkyl group of from 1 to 4 carbon atoms,
- p and q are 0 or 1, except that both p and q preferably are not 1,
- m is 0 or 1 except that when m is 1 both p and q are 0 and at least one of Z, and Z2 represents imidazoline, oxazoline, thiazoline, or selenazoline,
- A is an anionic group,
- B is a cationic group, and
- k and I may be 0 or 1, depending on whether ionic substitutes are present. Variants are, of course, possible in which R1 and R3, R2 and Rs, or R1 and R2 together represent the atoms necessary to complete an alkylene bridge.
- Other references to well known spectral sensitizers can be found in Research Disclosure, Vol. 308, December 1989, Item 308119, Section IV. Research Disclosure is a publication of Kenneth Mason Publication Ltd., Emsworth, Hampshire P010 7DD, United Kingdom.
-
- R10 represents a hydrogen atom or a lower alkyl group of from 1 to 4 carbon atoms (e.g. methyl, and ethyl),
- R6, R7, R8 and Rg each represents a hydrogen atom, a halogen atom (e.g. chloro, bromo, iodo, and fluoro), a hydroxy group, an alkoxy group (e.g. methoxy and ethoxy), an amino group (e.g. amino, methylamino, and dimethylamino), an acylamino group (e.g. acetamido and propionamido), an acyloxy group (e.g. acetoxy group), an alkoxycarbonyl group (e.g. methoxycarbonyl, ethoxycarbonyl, and butoxycarbonyl), an alkyl group (e.g. methyl, ethyl, and isopropyl), an alkoxycarbonylamino group (e.g. ethoxycar- bonylamino) or an aryl group (e.g. phenyl and tolyl), or, together, R6 and R7 and, respectively, R8 and Rg can be the atoms necessary to complete a benzene ring (so that the heterocyclic nucleus results to be, for example, an a-naphthoxazole nucleus, a b-naphthoxazole or a b,b'-naphthoxazole),
- R11 and R12 each represents an alkyl group (e.g. methyl, propyl, and butyl), a hydroxyalkyl group (e.g. 2-hydroxyethyl, 3-hydroxypropyl, and 4-hydroxybutyl), an acetoxyalkyl group (e.g. 2-acetoxyethyl and 4-acetoxybutyl), an alkoxyalkyl group (e.g. 2-methoxyethyl and 3-methoxypropyl), a carboxyl group containing alkyl group (e.g. carboxymethyl, 2-carboxyethyl, 4-carboxybutyl, and 2-(2-carboxyethoxy)-ethyl), a sulfo group containing alkyl group (e.g. 2-sulfoethyl, 3-sulfopropyl, 4-sulfobutyl, 2-hydroxy-3-sulfopropyl, 2-(3-sulfopropoxy)-propyl, p-sulfobenzyl, and p-sulfophenethyl), a benzyl group, a phenetyl group, a vinylmethyl group, and the like,
- X- represents an acid anion (e.g. a chloride, bromide, iodide, thiocyanate, methylsulfate, ethylsulfate, perchlorate, and p-toluensulfonate ion), and
- n represents 1 or 2.
- The alkyl groups included in said substitutes R6, R7, R8, Rg, Rio, and R11 and, more particularly, the alkyl portions of said alkoxy, alkoxycarbonyl, alkoxycarbonylamino, hydroxyalkyl, acetoxyalkyl groups and of the alkyl groups associated with a carboxy or sulfo group each preferably contain from 1 to 12, more preferably from 1 to 4 carbon atoms, the total number of carbon atoms included in said groups preferably being no more than 20.
- The aryl groups included in said substituents R6, R7, R8 and Rg each preferably contain from 6 to 18, more preferably from 6 to 10 carbon atoms, the total number of carbon atoms included in said groups arriving up to 20 carbon atoms.
-
- The silver halide emulsion layers can contain other constituents generally used in photographic products, such as binders, hardeners, surfactants, speed-increasing agents, stabilizers, plasticizers, gelatin extenders, optical sensitizers, dyes, ultraviolet absorbers, etc., and reference to such constituents can be found, for example, in Research Disclosure, Vol. 176, December 1978, Item 17643, Vol. 184, August 1979, Item 18431 and Vol 308, December 1989, Item 308119.
- The radiographic element of this invention can be prepared by coating the light-sensitive silver halide emulsion layers and other auxiliary layers on a support. Examples of materials suitable for the preparation of the support include glass, paper, polyethylene-coated paper, metals, polymeric film such as cellulose nitrate, cellulose acetate, polystyrene, polyethylene terephthalate, polyethylene, polypropylene and other well known supports. Preferably, the silver halide emulsion layers are coated on the support at a total silver coverage of at least 1 g/m2, preferably in the range of from 2 to 5 g/m2.
- Auxiliary layers can be represented by top-coating layers, antistatic layers, antihalo layer, protective layers, dye underlayers, and the like. Dye underlayers are particularly useful in order to reduce the crossover of the double coated silver halide radiographic material of the present invention. Reference to well-known dye underlayer can be found in US 4,900,652, US 4,855,221, US 4,857,446, 4,803,150. According to a preferred embodiment of the present invention a dye underlayer is coated on at least one side of the support, more preferably on both sides of the support, before the coating of said at least two silver halide emulsions.
- In another aspect this invention relates to a symmetrical radiographic assembly comprising:
- - a double side radiographic element which comprises a support and hydrophilic colloid layers coated on each side of said support, and
- - an intensifying screen adjacent to each side of said radiographic element,
- As employed herein the term "symmetrical radiographic assembly" refers to a radiographic assembly which comprises a silver halide double coated radiographic element comprising substantially identical silver halide emulsion layers coated on each side of the support, said radiographic element being interposed between a pair of intensifying screens.
- The radiographic element according to the present invention is associated with the intensifying screens so as to be exposed to the radiations emitted by said screens. The pair of screens employed in combination with the radiographic element of the present invention is symmetrical. The screens are made of relatively thick phosphor layers which transform the x-rays into light radiation (e. g., visible light). The screens absorb a portion of x-rays much larger than the radiographic element and are used to reduce the radiation dose necessary to obtain a useful image.
- The phosphors used in the intensifying screens applied in the present invention have an emission maximum wavelength in the ultraviolet, blue, green, red or infrared region of the electromagnetic spectrum according to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive. More preferably, said phosphors emit radiations in the ultraviolet, blue and green regions of the electromagnetic spectrum.
- The green emitting phosphors emit radiation having more than about 80% of its spectral emission above 480 nm and its maximum of emission in the wavelength range of 530-570 nm. Green emitting phosphors which may be used in the intensifying screens of the present invention include rare earth activated rare earth oxysulfide phosphors of at least one rare earth element selected from yttrium, lanthanum, gadolinium and lutetium, rare earth activated rare earth oxyhalide phosphors of the same rare earth elements, a phosphor composed of a borate of the above rare earth elements, a phosphor composed of a phosphate of the above rare earth elements and a phosphor composed of tantalate of the above rare earth elements. These rare earth green emitting phosphors have been extensively described in the patent literature, for example in US Patents 4,225,653, 3,418,246, 3,418,247, 3,725,704, 3,617,743, 3,974,389, 3,591,516, 3,607,770, 3,666,676, 3,795,814, 4,405,691, 4,311,487 and 4,387,141. These rare earth phosphors have a high X-ray absorbing power and high efficiency of light emission when excited with X radiation and enable radiologists to use substantially lower X radiation dosage levels. Particularly suitable phosphors for use in the intensifying screens of the present invention are terbium or terbium-thulium activated rare earth oxysulfide phosphors represented by the following general formula:
- The UV-blue emitting phosphors emit radiation having more than about 80% of their spectral emission below 450 nm and their maximum of emission in the wavelength range of 300-400 nm. UV-blue emitting phosphors which may be used in the intensifying screens of the present invention include UV-blue emitting phosphors known in the art such as lead or lanthanum activated barium sulfate phosphors, barium fluorohalide phosphors, lead activated barium silicate phosphors, gadolinium activated yttrium oxide phosphors, barium fluoride phosphors, alkali metal activated rare earth niobate or tantalate phosphors etc. UV-blue emitting phosphors are described for example in BE 703,998 and 757,815, in EP 202,875 and by Buchanan et al., J. Applied Physics, vol. 9, 4342-4347, 1968,and by Clapp and Ginther, J. of the Optical Soc. of America, vol. 37, 355-362,1947. Particularly suitable UV-blue emitting phosphors for use in the intensifying screens of the present invention are those represented by the following general formula:
x 1 1 and 10-4 < y 0.1 as described in EP 202,875. - References to other well known kind of light emitting phosphors can be found in Research Disclosure, Vol. 184, August 1979, Item 18431, Section IX.
- The intensifying screens of this invention have a fluorescent layer comprising a binder and at least one phosphor dispersed therein. The fluorescent layer is formed by dispersing the phosphor(s) in the binder to prepare a coating dispersion having the desired phosphor weight ratio, and then applying the coating dispersion by a conventional coating method to form a uniform layer. Although the fluorescent layer itself can be an intensifying screen when the fluorescent layer is self-supporting, the fluorescent layer is generally provided on a substrate to form an intensifying screen. Further, a protective layer for physically and chemically protecting the fluorescent layer is usually provided on the surface of the fluorescent layer. Furthermore, a primer layer is sometimes provided between the fluorescent layer and the substrate to closely bond the fluorescent layer to the substrate, and a reflective layer is sometimes provided between the substrate (or the primer) and the fluorescent layer.
- The binder employed in the fluorescent layer of the intensifying screens of the present invention, can be, for example, one of the binders commonly used in forming layers: gum arabic, protein such as gelatin, polysaccharides such as dextran, organic polymer binders such as polyvinylbutyral, polyvinylacetate, nitrocellulose, ethylcellulose, vinylidene-chloride-vinylchloride copolymer, polymethylmethacrylate, polybutylmethacrylate, vinylchloride-vinylacetate copolymer, polyurethane, cellulose acetate butyrate, polyvinyl alcohol, and the like.
- Generally, the binder is used in an amount of 0.01 to 1 part by weight per one part by weight of the phosphor. However, from the viewpoint of the sensitivity and the sharpness of the screen obtained, the amount of the binder should preferably be small. Accordingly, in consideration of both the sensitivity and the sharpness of the screen and the easiness of application of the coating dispersion, the binder is preferably used in an amount of 0.03 to 0.2 parts by weight per one part by weight of the phosphor. The thickness of the fluorescent layer is generally within the range of 10 µm to 1 mm.
- In the intensifying screens of the present invention, the fluorescent layer is generally coated on a substrate. As the substrate, various materials such as polymeric material, glass, wool, cotton, paper, metal, or the like can be used. From the viewpoint of handling the screen, the substrate should preferably be processed into a sheet or a roll having flexibility. In this connection, as the substrate is preferably either a plastic film (such as a cellulose triacetate film, polyester film, polyethylene terephthalate film, polyamide film, polycarbonate film, or the like), or ordinary paper or processed paper (such as a photographic paper, baryta paper, resin-coated paper, pigment-containing paper which contains a pigment such as titanium dioxide, or the like). The substrate may have a primer layer on one surface thereof (the surface on which the fluorescent layer is provided) for the purpose of holding the fluorescent layer tightly. As the material of the primer layer, an ordinary adhesive can be used. In providing a fluorescent layer on the substrate (or on the primer layer or on the reflective layer), a coating dispersion comprising the phosphor dispersed in a binder may be directly applied to the substrate (or to the primer layer or to the reflective layer).
- Further in the intensifying screens of the present invention, a protective layer for physically and chemically protecting the fluorescent layer is generally provided on the surface of the fluorescent layer intended for exposure (on the side opposite the substrate). When, as mentioned above, the fluorescent layer is self-supporting, the protective layer may be provided on both surfaces of the fluorescent layer. The protective layer may be provided on the fluorescent layer by directly applying thereto a coating dispersion to form the protective layer thereon, or may be provided thereon by bonding thereto the protective layer formed beforehand. As the material of the protective layer, a conventional material for a protective layer such a nitrocellulose, ethylcellulose, cellulose acetate, polyester, polyethyleneterephthalate, and the like can be used.
- The intensifying screens of the present invention may be colored with a dye. Further, the fluorescent layer may contain a white powder dispersed therein. By using a dye or a white powder, an intensifying screen which provides an image of high sharpness can be obtained.
- In a further aspect, the present invention relates to a process for obtaining a radiographic image comprising the step of (a) image-wise exposing to an X-ray radiation which has passed through an object (particularly an animal or human body for medical radiographic imaging), a symmetrical radiographic assembly comprising (i) a double side radiographic element having a support and at least two silver halide emulsion layers having a speed difference of at least 0.3 logE coated on each side thereof, said at least two silver halide emulsion layers being each sensitive to the same region of the electromagnetic spectrum, and (ii) an intensifying screen comprising a light emitting phosphors selected to have a radiation light emission having an emission maximum wavelength corresponding to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive, and (b) developing said exposed radiographic element.
- In addition to the features specifically described above, the radiographic elements of this invention, in the silver halide emulsion layers or in other layers, can include additional addenda of conventional nature, such as stabilizers, antifoggants, brighteners, absorbing materials, hardeners, coating aids, plasticizers, lubricants, mating agents, antikinking agents, antistatic agents, and the like, as described in Research Disclosure, Vol. 176, December 1978, Item 17643, in Research Disclosure, Vol. 184, August 1979 Item 18431, and in Research Disclosure, Vol. 308, December 1989, Item 308119.
- As regards the processes for the silver halide emulsion preparation and the use of particular ingredients in the emulsion and in the light-sensitive element, reference is made to Research Disclosure 184, Item 18431, August 1979, wherein the following chapters are dealt with in deeper details:
- IA. Preparation, purification and concentration methods for silver halide emulsions.
- IB. Emulsion types.
- IC. Crystal chemical sensitization and doping.
- II. Stabilizers, antifogging and antifolding agents.
- IIA. Stabilizers and/or antifoggants.
- IIB. Stabilization of emulsions chemically sensitized with gold compounds.
- IIC. Stabilization of emulsions containing polyalkylene oxides or plasticizers.
- IID. Fog caused by metal contaminants.
- IIE. Stabilization of materials comprising agents to increase the covering power.
- IIF. Antifoggants for dichroic fog.
- IIG. Antifoggants for hardeners and developers comprising hardeners.
- IIH. Additions to minimize desensitization due to folding.
- III. Antifoggants for emulsions coated on polyester bases.
- IIJ. Methods to stabilize emulsions at safety lights.
- IIK. Methods to stabilize x-ray materials used for high temperature. Rapid Access, roller processor transport processing.
-
- III. Compounds and antistatic layers.
- VI. Protective layers.
- V. Direct positive materials.
- VI. Materials for processing at room light.
- VII. X-ray color materials.
- VIII. Phosphors and intensifying screens.
- IX. Spectral sensitization.
- X. UV-sensitive materials
- XII. Bases
- The present invention will be thereafter described by reference to the following examples which are not intended to be limiting.
- An octahedral silver bromochloroiodide emulsion (Em. A) containing 84.4%M bromide, 14.4%M chloride and 1.2%M iodide was sulfur and gold chemically sensitized with gold thiocyanate complex, sodium p-toluenethiosulfonate,sodium p-toluenesulfinate and benzo-thiazoleiodoethylate, spectrally sensitized with the green sensitizing dye anhydro-5,5'-dichloro-9-ethyl-3,3'-bis-(3-sulfopropyl)-oxacarbocyanine hydroxide triethylamine salt, and added with resorcylaldehyde and dimethylol urea hardeners. The silver halide grains have an average crystal diameter of 0.7µm. When coated double side on a polyester support emulsion A shows an average contrast of about 2.8.
- A tabular silver bromoiodide emulsion (Em. B) containing 99.4%M bromide and 0.6%M iodide was chemically and spectrally sensitized as the above described emulsion A. The tabular silver halide grains have an average diameter of 1.35µm, an average thickness of 0.25µm and an aspect ratio of 5.4. When coated double side on a polyester support emulsion B shows an average contrast of about 2.3.
- Emulsion A and B show a difference in speed of about 0.5 logE.
- Emulsion A was coated as first emulsion layer on both sides of a 0,18mm blue polyester film at a silver coating weight of 1.3 g/m2 on each side. An emulsion blend was prepared by mixing equal parts (based on silver content) of emulsion A and B. This emulsion blend was coated over the first emulsion layer on both sides of the film at a silver coating weight of 1.0 g/m2. On both emulsion layers was applied a gelatin top coat with a gelatin thickness of 0.9µm.
- Emulsion A was coated as first emulsion layer on both sides of a 0,18mm blue polyester film at a silver coating weight of 1.5 g/m2 on each side. Emulsion B was coated over the first emulsion layer on both sides of the film at a silver coating weight of 1.0 g/m2. On both emulsion layers was applied a gelatin top coat with a gelatin thickness of 0.9µm.
- Both
films -
-
- The data of Tables 1 and 2 clearly show the improvement in terms of toe contrast value and average contrast of the
films - It is worth noting that the Kodak Insight™ Film has an unsimmetrical structure, as described in the above mentioned US 4,994,355, and accordingly, it requires a specific orientation in order to work well. Moreover, table 1 and 2 clearly show that the Kodak Insight™ Film also provides different results with different screens in terms of average contrast and toe contrast value. On the contrary, both
Films
wherein on each side of said support are coated at least two silver halide emulsion layers having a speed difference of at least 0.3 logE, said at least two silver halide emulsion layers being each sensitive to the same region of the electromagnetic spectrum,
wherein said intensifying screen comprises a light emitting phosphors selected to have a radiation light emission having an emission maximum wavelength corresponding to the region of the electromagnetic spectrum to which said at least two silver halide emulsion layers are sensitive, and
wherein said double side radiographic element shows a sensitometric curve having a toe contrast value higher than 0.45 and an average contrast higher than 1.40.
Claims (19)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19930121047 EP0661592B1 (en) | 1993-12-29 | 1993-12-29 | Radiographic assembly for chest examination |
DE1993626556 DE69326556T2 (en) | 1993-12-29 | 1993-12-29 | Radiographic assembly for breast examination |
JP32686994A JPH07209822A (en) | 1993-12-29 | 1994-12-28 | Symmetrical radiation-transmitting photograph assembly for chest examination |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19930121047 EP0661592B1 (en) | 1993-12-29 | 1993-12-29 | Radiographic assembly for chest examination |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0661592A1 true EP0661592A1 (en) | 1995-07-05 |
EP0661592B1 EP0661592B1 (en) | 1999-09-22 |
Family
ID=8213539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19930121047 Expired - Lifetime EP0661592B1 (en) | 1993-12-29 | 1993-12-29 | Radiographic assembly for chest examination |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0661592B1 (en) |
JP (1) | JPH07209822A (en) |
DE (1) | DE69326556T2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0754973A1 (en) * | 1995-07-19 | 1997-01-22 | Eastman Kodak Company | Radiographic elements suitable for medical diagnostic imaging employing a symmetrically coated emulsion combination |
EP0838720A1 (en) * | 1996-10-23 | 1998-04-29 | Imation Corp. | Sensitization process of silver halide photographic emulsion |
EP1203986A2 (en) * | 2000-11-06 | 2002-05-08 | Eastman Kodak Company | Low silver radiographic film and imaging assembly for thoracic imaging |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3912933A (en) * | 1973-10-17 | 1975-10-14 | Du Pont | Fine detail radiographic elements and exposure method |
US3923515A (en) * | 1974-06-24 | 1975-12-02 | Du Pont | X-Ray film with reduced print-through |
EP0084637A2 (en) * | 1982-01-27 | 1983-08-03 | Fuji Photo Film Co., Ltd. | Silver halide photographic light-sensitive material |
US5108881A (en) * | 1990-03-29 | 1992-04-28 | Eastman Kodak Company | Minimal crossover radiographic elements adapted for varied intensifying screen exposures |
-
1993
- 1993-12-29 DE DE1993626556 patent/DE69326556T2/en not_active Expired - Fee Related
- 1993-12-29 EP EP19930121047 patent/EP0661592B1/en not_active Expired - Lifetime
-
1994
- 1994-12-28 JP JP32686994A patent/JPH07209822A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3912933A (en) * | 1973-10-17 | 1975-10-14 | Du Pont | Fine detail radiographic elements and exposure method |
US3923515A (en) * | 1974-06-24 | 1975-12-02 | Du Pont | X-Ray film with reduced print-through |
EP0084637A2 (en) * | 1982-01-27 | 1983-08-03 | Fuji Photo Film Co., Ltd. | Silver halide photographic light-sensitive material |
US5108881A (en) * | 1990-03-29 | 1992-04-28 | Eastman Kodak Company | Minimal crossover radiographic elements adapted for varied intensifying screen exposures |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0754973A1 (en) * | 1995-07-19 | 1997-01-22 | Eastman Kodak Company | Radiographic elements suitable for medical diagnostic imaging employing a symmetrically coated emulsion combination |
EP0838720A1 (en) * | 1996-10-23 | 1998-04-29 | Imation Corp. | Sensitization process of silver halide photographic emulsion |
EP1203986A2 (en) * | 2000-11-06 | 2002-05-08 | Eastman Kodak Company | Low silver radiographic film and imaging assembly for thoracic imaging |
EP1203986A3 (en) * | 2000-11-06 | 2003-05-21 | Eastman Kodak Company | Low silver radiographic film and imaging assembly for thoracic imaging |
Also Published As
Publication number | Publication date |
---|---|
DE69326556D1 (en) | 1999-10-28 |
DE69326556T2 (en) | 2000-05-04 |
JPH07209822A (en) | 1995-08-11 |
EP0661592B1 (en) | 1999-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0591747B1 (en) | Multicontrast radiographic film-screen assembly | |
US5070248A (en) | Cassette with intensifying screens to be used with an x-ray film | |
US5432351A (en) | X-ray intensifying screen | |
EP1203983A1 (en) | High contrast visually adaptive radiographic film and imaging assembly for orthopedic imaging | |
EP0581065B1 (en) | Combination of photosensitive elements for use in radiography | |
EP0412730B1 (en) | An improved cassette and radiographic film combination | |
EP0661592B1 (en) | Radiographic assembly for chest examination | |
US6682868B1 (en) | Radiographic imaging assembly with blue-sensitive film | |
EP0345483B1 (en) | Light-sensitive elements for radiographic use and process for the formation of an X-ray image | |
EP0350883B1 (en) | Combination of photosensitive elements for use in radiography | |
EP0403874B1 (en) | Light-sensitive elements for radiographic use and process for the formation of an x-ray image | |
US6686115B1 (en) | Blue-sensitive film for radiography with desired image tone | |
US6686119B1 (en) | Blue-sensitive film for radiography and imaging assembly and method | |
US6686118B1 (en) | Blue-sensitive film for radiography and imaging assembly and method | |
US6686117B1 (en) | Blue-sensitive film for radiography with reduced dye stain | |
US6686116B1 (en) | Blue spectrally sensitized film for radiography, imaging assembly and method | |
US6673507B1 (en) | Radiographic film for mammography with improved processability | |
JP4643585B2 (en) | High-speed radiography film | |
EP1385049B1 (en) | Asymmetric radiographic film for mammography and method of processing | |
EP1315039A2 (en) | Low silver radiographic film with improved visual appearance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB IT NL |
|
17P | Request for examination filed |
Effective date: 19951214 |
|
17Q | First examination report despatched |
Effective date: 19980211 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: IMATION CORP. |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR GB IT NL |
|
ITF | It: translation for a ep patent filed |
Owner name: BARZANO' E ZANARDO MILANO S.P.A. |
|
REF | Corresponds to: |
Ref document number: 69326556 Country of ref document: DE Date of ref document: 19991028 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: EASTMAN KODAK COMPANY |
|
ET | Fr: translation filed | ||
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: EASTMAN KODAK COMPANY |
|
NLXE | Nl: other communications concerning ep-patents (part 3 heading xe) |
Free format text: PAT. BUL. 12/99 PAGE 1709: CORR.: EASTMAN KODAK COMPANY |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20001204 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20010921 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20011102 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020830 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20021229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030701 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20021229 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20030701 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20031230 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051229 |